Norges Bank’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-517,380
Closed -$168M 2004
2024
Q1
$168M Buy
517,380
+156,553
+43% +$38.4M 0.03% 483
2023
Q4
$68.8M Sell
360,827
-257,246
-42% -$48.6M 0.01% 757
2023
Q3
$123M Buy
618,073
+41,035
+7% +$9.7M 0.03% 510
2023
Q2
$165M Sell
577,038
-112,643
-16% -$31.3M 0.03% 439
2023
Q1
$150M Buy
689,681
+179,093
+35% +$34.9M 0.03% 443
2022
Q4
$105M Buy
510,588
+74,814
+17% +$18.9M 0.03% 521
2022
Q3
$121M Sell
435,774
-129,699
-23% -$33M 0.03% 453
2022
Q2
$108M Buy
565,473
+175,160
+45% +$30.9M 0.03% 497
2022
Q1
$80.9M Buy
390,313
+253,796
+186% +$41.8M 0.02% 659
2021
Q4
$24.3M Buy
136,517
+62,161
+84% +$12.3M 0.01% 1366
2021
Q3
$15.3M Sell
74,356
-20,725
-22% -$4.07M ﹤0.01% 1619
2021
Q2
$18M Sell
95,081
-153,538
-62% -$25.1M ﹤0.01% 1587
2021
Q1
$32.4M Buy
248,619
+222,206
+841% +$26.7M 0.01% 1249
2020
Q4
$2.74M Buy
+26,413
New +$2.29M ﹤0.01% 1925
2019
Q2
Sell
-20,000
Closed -$669K 2138
2019
Q1
$669K Buy
+20,000
New +$664K ﹤0.01% 2068

Other funds holding SWAV

Norges Bank's SWAV Position: Q2 2024 in Review

Norges Bank sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 517,380 shares — an estimated $168M sold.

Norges Bank first reported a position in SWAV in Q1 2019 and held it in 15 quarters. The position peaked at $168M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Norges Bank reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Norges Bank sold 517,380 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $168M.
  • Norges Bank first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Norges Bank's Shockwave Medical, Inc. Common Stock position peaked at $168M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Norges Bank's 13F filing for Q2 2024, filed 14 Aug 2024.